Skip to content

Reduce Medication Errors by Translating AESOP Model Into CPOE Systems

Using Big Data and Deep Neural Network to Prevent Medication Errors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03484793
Acronym
AESOP
Enrollment
37
Registered
2018-04-02
Start date
2017-05-01
Completion date
2018-02-28
Last updated
2018-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

AESOP Model, Big data, medication error, data mining, patient safety, CPOE, CDSS, alarm fatigue, association rule mining.

Brief summary

Medication errors are common, life-threatening, costly but preventable. Information technology and automated systems are highly efficient for preventing medication errors and therefore widely employed in hospital settings. In this study, investigators would perform a cluster randomized controlled trial of a clinical reminding system that uses DNN and Probabilistic models to detect and notify physicians of inappropriate prescriptions, giving them the opportunity to correct these gaps and increase prescriptions completeness. This study aim is to assess whether or not this system would improve prescription notation for a broad array of patient conditions.

Detailed description

This paper focuses on Big data in the knowledge base, using Data minig study of DM (Disease-Medication) and MM (Medication-Medication) of relevance to develop associated decision resources system-the intelligent safety system (Advanced Electronic Safety of Prescriptions,AESOP Model), and test the system in the clinical environment in hospital can assist physicians when open orders reduce medication errors, the system is named AESOP Model.

Interventions

OTHERAESOP service system

Investigators develop an electronic reminder in CPOE system which notifies physicians when there appears to be an inappropriate prescription. At the time, a physician saves a typed prescription, our system analyzes the patient's medications, diseases and uses the knowledge base to determine whether a medication is uncommonly prescribed to all diseases in a given prescription. If the system detects the common associations of medications and diseases in a given prescription, it considers an appropriate prescription, and, if not, an actionable reminder is shown onscreen. To the right of each suggested uncommon medication is a reason why the reminder is appearing. Physicians can accept the reminder or ignore the reminder.

Sponsors

Ministry of Science and Technology, Taiwan
CollaboratorOTHER_GOV
Taipei Medical University Shuang Ho Hospital
CollaboratorOTHER
Taiwan College of Healthcare Executives
CollaboratorUNKNOWN
Taipei Medical University Taipei Municipal Wan Fang Hospital
CollaboratorUNKNOWN
Case Western Reserve University
CollaboratorOTHER
Cardinal Tien Hospital
CollaboratorOTHER
Yong He Cardinal Tien Hospital
CollaboratorUNKNOWN
Chang Hua Christian Hospital
CollaboratorUNKNOWN
Taipei Medical University Hospital
CollaboratorOTHER
Taipei Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Physicians who are working at the outpatient clinics in hospitals. * Physicians who sign the consent form

Exclusion criteria

* Physicians who are unable to participate in this trial for the whole process * Physicians who do not sign the consent form

Design outcomes

Primary

MeasureTime frameDescription
The acceptance rate of reminder between two groups intervention and control3 monthsThe primary outcome of this study is the acceptance rate of the reminder, defined as the number of reminders accepted divided by number of unique reminders presented. In certain instances, physicians might see the same reminder serially, so we aggregate presentations and acceptance of the same reminder for the same patients' prescriptions in our calculation of the acceptance rate.

Secondary

MeasureTime frameDescription
The changes in the number of reminder for each group3 monthsAs a secondary outcome, we measure the number of inappropriate prescriptions rate documented in the two groups during the two time periods and calculate the unadjusted relative rate of inappropriateness notation in the intervention group by comparing the number of inappropriateness recorded in the intervention arm during the intervention period to all other groups. The unadjusted relative rate is defined as the ratio (errorsintervention-post/errorscontrol-post)/ (errorsintervention-pre/errorscontrol-pre).

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026